VanessaKHinsonMD

Movement Disorder

Associate Professor, Neurosciences, Medical University of South Carolina College of Medicine

Dr. Hinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog) Start of enrollment: 2012 Nov 01
Completed
Phase 2
taVNS in Mild to Moderate Parkinson's Disease Start of enrollment: 2018 Mar 20
Completed
Not Applicable
A Study of TAK-071 in People With Parkinson Disease Start of enrollment: 2020 Oct 21
Completed
Phase 2
Roles: Principal Investigator

PubMed

Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.
Fulya Akçimen, Kimberly Paquette, Peter Wild Crea, Paula Saffie-Awad, Charles Achoru
Medrxiv. 2025-01-20
The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocol.
Lana M Chahine, Naomi Louie, J Solle, Fulya Akçimen, Andrew Ameri
BMC Neurology. 2024-10-21
15 citations
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Ana Westenberger, Volha Skrahina, Tatiana Usnich, Christian Beetz, Eva-Juliane Vollstedt
Brain. 2024-08-01

Parkinson's Foundation Designates Three Centers of Excellence in Parkinson's CareJuly 24th, 2018
ADHD Drug Fails to Boost Cognition in Parkinson'sJune 24th, 2016
The Medical University of South Carolina Will Be One of Four Sites Exploring the Genetic Basis of Parkinson’s Disease in the Black CommunityFebruary 8th, 2024